Obesity: Drugs
Commons · Question 18898 · Tabled 14 Jul 2026 · Department of Health and Social Care · Official record
Answered 7 Sep 2026
Question
Asked by Darren Paffey
To ask the Secretary of State for Health and Social Care, what assessment he has made of variations between integrated care boards in access to weight-loss injections such as tirzepatide for weight management; whether the funding provided to integrated ca
Answer
Answered by James Frith, 7 Sep 2026
In December 2024, the National Institute for Health and Care Excellence (NICE) recommended tirzepatide, also known as Mounjaro, for managing obesity.In anticipation of the expected demand and the need to deliver treatment safely in primary care, NICE agre...